Find investors
← Back to all investors
CS
ResearchedAngel Investors

Chirag Sachdev

Investment Analyst

Angel InvestorsSeed Round
Pitch Chirag

Get their honest, personalized take on your startup.

Sign in to pitch Chirag

At a glance

Full Name
Chirag Mahesh Sachdev
Title
Managing Director (former, CX Partners); Director, Advantage Partners (since July 2025)
Firm
CX Partners (CX Advisors LLP)
Firm Type
Mid-market private equity / buyout fund — *not an angel or seed investor, despite the stub label*
Investment Stage
Mid-market buyouts and growth/minority investments (control and significant-minority stakes in established, profitable companies)
Check Size
Fund-level; across his career he has led/co-led ~12 investments representing ~US$600M of enterprise value (individual equity checks not publicly disclosed)
Target Company Profile
Established, profitable Indian mid-market companies with proven business models
Sector Focus
Healthcare, Consumer Products & Services, Financial Services / Insurance, IT & Outsourced/Technology Services
Geographic Focus
India (with a broader Asia mandate in his current Advantage Partners role)
Location
New Delhi / Gurugram, India

Background

Chirag Sachdev is a private-equity investment professional with more than 11 years of experience in Indian mid-market buyouts and minority investments. He spent the core of his career at CX Partners, an Indian mid-market-focused buyout firm founded by former Citi/CVCI executive Ajay Relan, which he joined in 2018 and where he rose to Managing Director. CX Partners manages roughly US$630M across SEBI-registered Category-II Alternative Investment Funds (via CX Advisors LLP) and invests in healthcare, financial services, consumer, and IT/outsourced-services businesses. It is important to note that CX Partners is a control/growth buyout fund, not an angel or seed-stage investor — the "Angel Investors / Seed Round / Investment Analyst" labels in the source stub do not match the verified record.

Before CX Partners, Sachdev spent about four years at Access Private Equity, a lower-mid-market fund in India, where he worked on consumer, insurance, and telecom deals. He began his career in the financial services audit practice at KPMG. Across his PE career he has been involved in roughly 12 company investments totaling approximately US$600M in enterprise value.

He is a qualified Chartered Accountant (ICAI) and holds an MBA from the Indian School of Business (ISB), Hyderabad, and a B.Com from Narsee Monjee College, University of Mumbai. In 2022 he was recognized as one of India's "40 under 40" Alternative Investment Professionals (Equalifi).

In July 2025 he moved to Advantage Partners, a Japan-headquartered, Asia-focused private equity firm, where he serves as a Director on its Asia investment team. His CX Partners contact details remain the identifiers provided, so this profile is anchored to his CX Partners identity while noting the recent move.

Investment Thesis & Focus

  • Invests as a mid-market private equity / buyout investor, not at the angel or seed stage — targeting established, cash-generative Indian companies rather than early-stage startups.
  • Core sectors: healthcare, consumer products & services, financial services/insurance, and IT / outsourced (technology) services — mirroring both his personal deal history and CX Partners' mandate.
  • CX Partners' stated approach emphasizes "involved ownership, alignment of interests," and "pushing the envelope on value creation while maintaining the fine balance between entrepreneurial energy and prudence" — i.e. hands-on, board-level partnership with founders.
  • Typically takes board seats or board-observer roles and drives operational value creation, consistent with a control/significant-minority buyout style.

Notable Investments

  • Nobel Hygiene — Indian adult-diaper / hygiene products maker; cited among his consumer investments.
  • Alliance Insurance Brokers — insurance brokerage; among his financial-services deals.
  • Veeda Clinical Research (Veeda Life Sciences) — CRO where he serves as Non-Executive Nominee Director (DIN: 08567477).
  • Sabine Hospital & Research Centre — healthcare provider; board member.
  • Bioneeds India — preclinical/CRO services company; board member.
  • Transaction Solutions International (India) — ATM/payments services; board member.
  • BetterPlace Safety Solutions — blue-collar workforce management platform; board observer.

Unlock the full research

Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.

One-time. Stays unlocked for you.